These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 741437)

  • 1. Appearance of heparin antithrombin-active chains in vivo after injection of commercial heparin and in anaphylaxis.
    Levy SW; Jaques LB
    Thromb Res; 1978 Sep; 13(3):429-41. PubMed ID: 741437
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies of heparin affinity to antithrombin III and other proteins in vitro and in vivo.
    Takeda Y; Kobayashi N
    Thromb Haemost; 1977 Oct; 38(3):685-95. PubMed ID: 579514
    [No Abstract]   [Full Text] [Related]  

  • 3. Crossed immunoelectrophoresis as applied to studies on complex formation. The binding of heparin to antithrombin III and the antithrombin III--thrombin complex.
    Andersson LO; Engman L; Henningsson E
    J Immunol Methods; 1977; 14(3-4):271-81. PubMed ID: 557071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3H-heparin and antithrombin III in the isolated liver perfusion.
    Losito R; Barlow G; Lemieux E
    Thromb Res; 1977 Jan; 10(1):83-93. PubMed ID: 850904
    [No Abstract]   [Full Text] [Related]  

  • 5. Determination of the range in binding-site densities of rat skin heparin chains with high binding affinities for antithrombin.
    Horner AA; Kusche M; Lindahl U; Peterson CB
    Biochem J; 1988 Apr; 251(1):141-5. PubMed ID: 3390150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The observation of heparin on endothelium after injection.
    Hiebert LM; Jaques LB
    Thromb Res; 1976 Feb; 8(2):195-204. PubMed ID: 1251350
    [No Abstract]   [Full Text] [Related]  

  • 7. Isoform composition of antithrombin in a covalent antithrombin-heparin complex.
    Chan AK; Berry LR; Paredes N; Parmar N
    Biochem Biophys Res Commun; 2003 Oct; 309(4):986-91. PubMed ID: 13679071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A heparin analogue with specific action on antithrombin III.
    Thomas DP; Lane DA; Michalski R; Johnson EA; Kakkar VV
    Lancet; 1977 Jan; 1(8003):120-2. PubMed ID: 64653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of plasmin by antithrombin-heparin complex. II. During thrombolytic therapy in man.
    Collen D; Semeraro N; Telesforo P; Verstraete M
    Br J Haematol; 1978 May; 39(1):101-10. PubMed ID: 149555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetics of heparin after a single intravenous or subcutaneous injection].
    Mombelli G; Schaedelin J; Beck EA
    Schweiz Med Wochenschr; 1977 Jun; 107(23):810-5. PubMed ID: 877532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The kinetics of heparin.
    Estes JW
    Ann N Y Acad Sci; 1971 Jul; 179():187-204. PubMed ID: 5285374
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of heparin and heparinlike molecules in thrombosis and atherosclerosis.
    Rosenberg RD
    Fed Proc; 1985 Feb; 44(2):404-9. PubMed ID: 3155697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Location of antithrombin-binding regions in rat skin heparin proteoglycans.
    Jacobsson KG; Lindahl U; Horner AA
    Biochem J; 1986 Dec; 240(3):625-32. PubMed ID: 3827857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A fragment of antithrombin that binds both heparin and thrombin.
    Rosenfeld L; Danishefsky I
    Biochem J; 1986 Aug; 237(3):639-46. PubMed ID: 3800906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly active heparin species with multiple binding sites for antithrombin.
    Rosenberg RD; Jordan RE; Favreau LV; Lam LH
    Biochem Biophys Res Commun; 1979 Feb; 86(4):1319-24. PubMed ID: 571279
    [No Abstract]   [Full Text] [Related]  

  • 16. The antithrombin P1 residue is important for target proteinase specificity but not for heparin activation of the serpin. Characterization of P1 antithrombin variants with altered proteinase specificity but normal heparin activation.
    Chuang YJ; Swanson R; Raja SM; Bock SC; Olson ST
    Biochemistry; 2001 Jun; 40(22):6670-9. PubMed ID: 11380262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for heparin binding variants of antithrombin.
    Harper PL; Daly M; Price J; Edgar PF; Carrell RW
    J Clin Pathol; 1991 Jun; 44(6):477-9. PubMed ID: 2066426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micromethod for the determination of heparin in plasma after intravenous and subcutaneous administration.
    Oreste P; Peruzzi M; Stella P
    Anal Biochem; 1993 Apr; 210(1):136-9. PubMed ID: 8489009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding to antithrombin of heparin fractions with different molecular weights.
    Danielsson A; Björk I
    Biochem J; 1981 Feb; 193(2):427-33. PubMed ID: 7305940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rat heparins. A study of the relative sizes and antithrombin-binding characteristics of heparin proteoglycans, chains and depolymerization products from rat adipose tissue, heart, lungs, peritoneal cavity and skin.
    Horner AA
    Biochem J; 1986 Nov; 240(1):171-9. PubMed ID: 3827837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.